::INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES::

CODEN : IAJPBB
issn 2349-7750

News Updates Latest Volumes: COSMOS IMPACT FACTOR (2018)- 4.153, GLOBAL IMPACT FACTOR(2014) - 0.384, (2015) - 0.437, Indo American Journal of Pharmaceutical Sciences,

ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

TITLE:

ASSESSMENT OF HEALTH-RELATED QUALITY OF LIFE PATIENTS UNDERGOING TREATMENT OF HEPATITIS C COMING TO HEPATITIS CLINIC IN JINNAH HOSPITAL LAHORE

AUTHORS:

Dr Saira Bakhtawer, Dr Sadia Zia, Dr Sadia Tarar

ABSTRACT:

Background: In recent past years Hepatitis C burden in Pakistan is keep on increasing. In this article we assessed the Health-related quality of life (HROOL)of Hepatitis C patients undergoing antiviral treatment especially interferon Antiviral treatment cause significant side effects on quality of life of patient. Methodology: In this study short form 36(sf-36) questionnaire was used to assess of quality of life of 121 antiviral treated hepatitis c patients.36 items of sf-36 were divided in to 8 scales and mean score was calculated for each scale. Descriptive statistic measures were used for data analysis. Result: Subject showed scores below 50 in 7 out of 8 scale which indicated poor health related quality of life(HROOL) Hepatitis C patients on antiviral treatment. HROOL was affected in both genders equally regardless of treatment of duration. Conclusion: The study indicated poor health quality of life (HROOL)of antiviral especially interferon treated Hepatitis C patients. the study highlighted need of monitoring of health status throughout. the result can be used as reference to improve healthcare facilities for Hepatitis C patients under antiviral treatment. Keywords: Hepatitis C, antiviral treatment, interferon, health related quality of life of patient.